Vagus nerve stimulation was recently approved by the U.S. Food and Drug Administration(FDA) as an adjunctive treatment for chronic or recurrent depression. Here are some basic definitions to help you better understand this remarkable treatment:
Tests of the effectiveness and safety of a treatment on people who have the illness the treatment is intended to help.
A period of depression.
Anesthesia that makes the patient unconscious.
A device-like a pacemaker that sends impulses to the brain via the left vagus nerve.
Happening more than once. Recurrent depression refers to several episodes of depression occurring over time.
A neurotransmitter implicated in depression.
One of the primary communication pathways from the major organs of the body to the brain, the vagus nerves travel from major body organs to the brain. VNS Therapy involves the left vagus nerve only.
You can learn more about neurostimulation and vagus nerve stimulation for depression on the http://www.VagusNerveStimulator.com web site.
Charles Donovan was a patient in the FDA investigational trial of vagus nerve stimulation as a treatment for chronic or recurrent treatment-resistant depression. He was implanted with the vagus nerve stimulator in April of 2001. He chronicles his journey from the grips of depression thanks to vagus nerve stimulation therapy in his book:
Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression with Forwards by John M. Zajecka, M.D. and Nancy Williger, Ph.D.
The book was exhibited at the U.S. Psychiatric and Mental Health Congress in November 2005. It is available on his web site, 24 hours a day/7 days a week through the toll free number 1-888-VAGUS-88, and Amazon.com He is founder of the http://www.VagusNerveStimulator.com Web Site and Bulletin.